AMRS News and Press, Amyris Inc. From 08/09/22

Amyris ( NASDAQ: AMRS ) saw its Q2 2022 net loss widen ~94% to $110M as the company missed on the top and bottom lines . Non-cash mark-to-market adjustments related to changes in the fair value of debt and derivatives contributed to the significant increase in net...

CorMedix CRMD -61% after FDA again rejects CorMedix's application for lead candidate DefenCath . Turtle Beach HEAR -32% on Q2 earnings miss . Novavax NVAX -31% on Q2 earnings release . Medicenna Therapeutics MDNA -29% on launch of units offeri...

Amyris press release ( NASDAQ: AMRS ): Q2 GAAP EPS of -$0.44 misses by $0.15 . Revenue of $65.21M (+24.6% Y/Y) misses by $16.32M . "We are moving beyond the period of significant investment and the constraints on our ingredients production capacity. We are ente...

AMYRIS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS PR Newswire Record consumer revenue of $43 million increased 108% compared to Q2 2021 Ingredients sold out in first half with $15 million backlog to be supplied in H2 Cost actions and ...

Gainers: W&T Offshore ( WTI ) +19% . Amyris ( AMRS ) +15% . Austin Gold ( AUST ) +13% . KLX Energy Services Holdings ( KLXE ) +12% . Genie Energy ( GNE ) +11% . Losers: Permianville Royalty Trust ( PVL ) -7% . Comstock Re...

Amyris ( NASDAQ: AMRS ) is scheduled to announce Q2 earnings results on Tuesday, August 9th, before market open. The consensus EPS Estimate is -$0.23 (-53.3% Y/Y) and the consensus Revenue Estimate is $81.53M (+55.8% Y/Y). Over the last 2 years, AMRS has beaten EPS e...

AMYRIS TO PARTICIPATE AT THE UBS GENOMICS 2.0 AND MEDTECH INNOVATIONS SUMMIT PR Newswire EMERYVILLE, Calif. , Aug. 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustai...

AMYRIS TO HOST SECOND QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 9 PR Newswire EMERYVILLE, Calif. , July 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to s...

Zymergen ( ZY ) +40% on $300M buyout deal with Ginkgo. Chimerix ( CMRX ) +30% sounds alarm over current outbreak. FaZe Holdings ( FAZE ) +28% . Infrastructure and Energy Alternatives ( IEA ) +26% to buy IEA in cash-and-stock deal value...

Gainers: UFP Industries ( UFPI ) +10% . Brenmiller Energy ( BNRG ) +7% . Losers: Fusion Fuel Green ( HTOOW ) -13% . Amyris ( AMRS ) -13% . Benson Hill ( BHIL ) -10% . Zymergen ( ZY ) -11% . Energy Vault Holdings ( NRGV ) ...